SCHEMBL24515752

SCHEMBL24515752

CC(C)(C)OC(=O)NC1CCCC1C(=O)OCc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CPB1 P15086 2/20 0.56
KMT2A Q03164 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
CTSB P07858 2/20 0.50
CTSS P25774 2/20 0.50
CTSK P43235 2/20 0.50
CASP3 P42574 3/20 0.49
CTSL P07711 2/20 0.49
PDE4B Q07343 1/20 0.47
TSHR P16473 2/20 0.46
SYK P43405 1/20 0.45
FKBP1A P62942 1/20 0.43
KDM1A O60341 1/20 0.43
MAOB P27338 1/20 0.43
ALDH1A1 P00352 1/20 0.43
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24515749 1.00 CPB1 (0.56) CPB1KMT2AL3MBTL1CTSBCTSS
SCHEMBL10137650 0.98 CPB1 (0.56) CPB1KMT2AL3MBTL1CTSBCTSS
SCHEMBL12873056 0.98 CPB1 (0.56) CPB1KMT2AL3MBTL1CTSBCTSS
SCHEMBL3563686 0.88 KMT2A (0.56) CPB1KMT2AL3MBTL1CTSBCTSS
SCHEMBL2496331 0.88 CACNA1B (0.51) CPB1KMT2AL3MBTL1CTSBCTSS
SCHEMBL4033681 0.85 CPB1 (0.54) CPB1KMT2AL3MBTL1CTSBCTSS
SCHEMBL30441712 0.85 KMT2A (0.53) CPB1KMT2AL3MBTL1CTSBCTSS
SCHEMBL12193476 0.84 KMT2A (0.48) CPB1KMT2AL3MBTL1CTSBCTSS
SCHEMBL13712268 0.83 CPB1 (0.78) CPB1CTSBCTSSCTSKCASP3
SCHEMBL14161287 0.83 CPB1 (0.78) CPB1CTSBCTSSCTSKCASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022122773-A1 4-(2-FLUORO-4-METHOXY-5-3-(((1-METHYLCYCLOBUTYL)METHYL)CARBAMOYL)BICYCLO[2.2.1]HEPTAN-2-YL)CARBAMOYL)PHENOXY)-1-METHYLCYCLOHEXANE-1-CARBOXYLIC ACID DERIVATIVES AND SIMILAR COMPOUNDS AS RXFP1 MODULATORS FOR THE TREATMENT OF HEART FAILURE ASTRAZENECA AB (SE) 2022-06-16 WO disclosed